Chief Executive, Healx
Trustee and Chair at Cambridge Rare Disease Network
Co-Founder at Cambridge University Science and Policy Exchange
Dr Tim Guilliams is a social entrepreneur from the Cambridge Cluster passionate about delivering the next generation of therapeutics to patients in need. He is the Founder and Chief Executive of Healx, a Bio-Tech startup focused on drug repositioning for rare diseases by use advanced computational methods. He is also a Founding Trustee and Chair of the Cambridge Rare Disease Network (CRDN), a charity aiming to foster dialogue and awareness around rare diseases in Cambridge.
Prior to Healx and CRDN, Dr Guilliams worked with the Centre for Science and Policy on University-Industry interactions and cluster dynamics in the area of Life Sciences at the Department for Business, Innovation and Skills (BIS). Resulting report can be found here. His PhD was obtained in the field of Biophysical Neuroscience at the University of Cambridge, where his research related to the development of antibody fragments as novel biophysical and therapeutic tools for Parkinson’s disease. As a PhD student, Tim co-founded multiple successful student societies, including the Cambridge University Science and Policy Exchange (CUSPE), where he worked closely with the Centre for Science and Policy as a Junior Associate Fellow. Before moving to Cambridge, he obtained an MEng & BEng in Bio-Engineering from the University of Brussels (VUB).
You can read about Tim's experience as a secondee with the Department of Business, Innovation and Skills here.